Sodium butyrate inhibits the NF-kappa B signaling pathway and histone deacetylation, and attenuates experimental colitis in an IL-10 independent manner
Keywords: Butyrates; Histone deactylase inhibitors; Inflammatory bowel diseases; Mice; NF-kappa B;